Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review
✍ Scribed by Elena Pentsova; Anli Liu; Marc Rosenblum; Eileen O’Reilly; Xi Chen; Adília Hormigo
- Publisher
- Springer US
- Year
- 2011
- Tongue
- English
- Weight
- 613 KB
- Volume
- 106
- Category
- Article
- ISSN
- 0167-594X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## BACKGROUND. In early phase I1 trials in advanced pancreatic cancer, gemcitabine demonstrated modest antitumor activity. The investigators in these studies reported that gemcitabine should be studied further in view of the degree and frequency of symptomatic improvement observed, the durability o
## BACKGROUND. In early phase I1 trials in advanced pancreatic cancer, gemcitabine demonstrated modest antitumor activity. The investigators in these studies reported that gemcitabine should be studied further in view of the degree and frequency of symptomatic improvement observed, the durability o
## Purpose: To evaluate whether celecoxib alters the conversion of gemcitabine into its active metabolite, difluorodeoxycytidine triphosphate (dfdctp), in peripheral blood mononuclear cells (pbmcs). ## Methods: Patients with advanced pancreatic cancer who had not received chemotherapy and had acc